Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Multiple system atrophy: a clinical and neuropathological perspective.

Ubhi K, Low P, Masliah E.

Trends Neurosci. 2011 Nov;34(11):581-90. doi: 10.1016/j.tins.2011.08.003. Epub 2011 Sep 29. Review.

PMID:
21962754
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.

Stemberger S, Poewe W, Wenning GK, Stefanova N.

Exp Neurol. 2010 Aug;224(2):459-64. doi: 10.1016/j.expneurol.2010.05.008. Epub 2010 May 21.

PMID:
20493840
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Multiple system atrophy: a primary oligodendrogliopathy.

Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG.

Ann Neurol. 2008 Sep;64(3):239-46. doi: 10.1002/ana.21465. Review.

PMID:
18825660
[PubMed - indexed for MEDLINE]
4.

Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy.

Nakayama K, Suzuki Y, Yazawa I.

Am J Pathol. 2009 Apr;174(4):1471-80. doi: 10.2353/ajpath.2009.080503. Epub 2009 Mar 12.

PMID:
19286568
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies.

Kisos H, Pukaß K, Ben-Hur T, Richter-Landsberg C, Sharon R.

PLoS One. 2012;7(10):e46817. doi: 10.1371/journal.pone.0046817. Epub 2012 Oct 15.

PMID:
23077527
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence.

Kuzdas D, Stemberger S, Gaburro S, Stefanova N, Singewald N, Wenning GK.

Exp Neurol. 2013 Sep;247:531-6. doi: 10.1016/j.expneurol.2013.02.002. Epub 2013 Feb 8.

PMID:
23399889
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The neuropathology, pathophysiology and genetics of multiple system atrophy.

Ahmed Z, Asi YT, Sailer A, Lees AJ, Houlden H, Revesz T, Holton JL.

Neuropathol Appl Neurobiol. 2012 Feb;38(1):4-24. doi: 10.1111/j.1365-2990.2011.01234.x. Review.

PMID:
22074330
[PubMed - indexed for MEDLINE]
8.

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.

Shults CW, Rockenstein E, Crews L, Adame A, Mante M, Larrea G, Hashimoto M, Song D, Iwatsubo T, Tsuboi K, Masliah E.

J Neurosci. 2005 Nov 16;25(46):10689-99.

PMID:
16291942
[PubMed - indexed for MEDLINE]
Free Article
9.

Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy.

Rockenstein E, Ubhi K, Inglis C, Mante M, Patrick C, Adame A, Masliah E.

Neuroreport. 2012 Mar 7;23(4):259-64. doi: 10.1097/WNR.0b013e3283509842.

PMID:
22314685
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Animal models of multiple system atrophy.

Stefanova N, Tison F, Reindl M, Poewe W, Wenning GK.

Trends Neurosci. 2005 Sep;28(9):501-6. Review.

PMID:
16043239
[PubMed - indexed for MEDLINE]
11.

Alpha-synuclein transgenic mice: relevance to multiple system atrophy.

Fillon G, Kahle PJ.

Mov Disord. 2005 Aug;20 Suppl 12:S64-6.

PMID:
16092093
[PubMed - indexed for MEDLINE]
12.

Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy.

Ubhi K, Rockenstein E, Mante M, Patrick C, Adame A, Thukral M, Shults C, Masliah E.

Neuroreport. 2008 Aug 27;19(13):1271-6. doi: 10.1097/WNR.0b013e32830b3661.

PMID:
18695506
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia.

Miller DW, Johnson JM, Solano SM, Hollingsworth ZR, Standaert DG, Young AB.

J Neural Transm. 2005 Dec;112(12):1613-24.

PMID:
16284907
[PubMed - indexed for MEDLINE]
14.

Screening of Toll-like receptors expression in multiple system atrophy brains.

Brudek T, Winge K, Agander TK, Pakkenberg B.

Neurochem Res. 2013 Jun;38(6):1252-9. doi: 10.1007/s11064-013-1020-5. Epub 2013 Mar 23.

PMID:
23525968
[PubMed - indexed for MEDLINE]
15.

Animal models of multiple system atrophy.

Fernagut PO, Tison F.

Neuroscience. 2012 Jun 1;211:77-82. doi: 10.1016/j.neuroscience.2011.09.044. Epub 2011 Sep 25. Review.

PMID:
21963351
[PubMed - indexed for MEDLINE]
16.

Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy.

Hasegawa T, Baba T, Kobayashi M, Konno M, Sugeno N, Kikuchi A, Itoyama Y, Takeda A.

Neurochem Int. 2010 Dec;57(8):857-66. doi: 10.1016/j.neuint.2010.09.002. Epub 2010 Sep 16.

PMID:
20849899
[PubMed - indexed for MEDLINE]
17.

Concomitant progressive supranuclear palsy and multiple system atrophy: more than a simple twist of fate?

Silveira-Moriyama L, González AM, O'Sullivan SS, Williams DR, Massey L, Parkkinen L, Ahmed Z, de Silva R, Chacón JR, Revesz T, Lees AJ, Holton JL.

Neurosci Lett. 2009 Dec 31;467(3):208-11. doi: 10.1016/j.neulet.2009.10.036. Epub 2009 Oct 14.

PMID:
19835934
[PubMed - indexed for MEDLINE]
18.

[Mechanism of neuronal degeneration of multiple system atrophy].

Yoshida M, Sone M.

Brain Nerve. 2009 Sep;61(9):1051-60. Review. Japanese.

PMID:
19803404
[PubMed - indexed for MEDLINE]
19.

Striatal transplantation for multiple system atrophy--are grafts affected by alpha-synucleinopathy?

Stefanova N, Hainzer M, Stemberger S, Couillard-Després S, Aigner L, Poewe W, Wenning GK.

Exp Neurol. 2009 Sep;219(1):368-71. doi: 10.1016/j.expneurol.2009.05.016. Epub 2009 May 19.

PMID:
19460374
[PubMed - indexed for MEDLINE]
20.

Multiple system atrophy: alpha-synuclein and neuronal degeneration.

Yoshida M.

Neuropathology. 2007 Oct;27(5):484-93. Review.

PMID:
18018485
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk